Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diagnostics
MedTech
Roche nabs European approval for second Alzheimer’s test
Roche has secured a European CE mark for its second Alzheimer’s test that can both help confirm the disease and rule it out.
Ben Adams
May 12, 2026 7:07am
Blood-based approach could detect early heart, kidney disease
May 12, 2026 7:00am
Nuvalent teams up with Guardant Health for companion diagnostics
May 4, 2026 2:48am
Labcorp raises guidance on diagnostics, lab services growth
Apr 30, 2026 8:31am
CareDx expands into cancer testing with $260M Naveris buy
Apr 30, 2026 2:29am
Rising costs push GE HealthCare to cut outlook amid restructure
Apr 29, 2026 8:58am
